Pacific Biosciences of California Inc (NASDAQ:PACB)
| 5.51 Delayed Data As of May 16 |  -0.33 / -5.65%Today’s Change | 4.51 Today|||52-Week Range 36.36 | -73.07% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $1.3B |
Company Description
Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. The firm's products and services include PacBio sequel system, consumables, analytical software and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Contact Information
Pacific Biosciences of California, Inc. 1305 O'Brien Drive Menlo Park California 94025 |
Employees
Shareholders
| Individual stakeholders | 6.77% |
| Mutual fund holders | 54.21% |
| Other institutional | 39.77% |
Top Executives
| Christian O. Henry | President, Chief Executive Officer & Director |
| Mark David van Oene | Chief Operating Officer |
| Susan G. Kim | Chief Financial Officer |
| Stephen W. Turner | Chief Technology Officer |
| Jonas Korlach | Chief Scientific Officer |
